ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1407

Characterization of Synovial Fluid T Cells in Polymyalgia Rheumatica: Implication of Th1 and Tc1 Effector Memory Profiles

Rosanne Reitsema1, Lieske Wekema2, Wayel Abdulahad1, Peter Heeringa3, Minke Huitema1, Maria Sandovici3, Annemieke Boots3, Elisabeth Brouwer3 and Kornelis van der Geest3, 1Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3University Medical Center Groningen, Groningen, Netherlands

Meeting: ACR Convergence 2021

Keywords: Polymyalgia Rheumatica (PMR), T-Lymphocyte

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I: Giant Cell Arteritis & Polymyalgia Rheumatica (1391–1419)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Polymyalgia Rheumatica (PMR) is a common rheumatic inflammatory disease in the elderly. PMR is characterized by synovial inflammation of (peri)articular structures in the shoulders and hips. Patients are treated with glucocorticoids. Targeted treatments are lacking since little is known about the synovial pathobiology of PMR. We aim to investigate the phenotype and function of various T cell subsets in blood and synovial fluid of patients with PMR.

Methods: Blood samples were obtained from 18 newly diagnosed PMR patients before treatment, and 36 age- and sex-matched healthy controls. In addition, paired blood and bursal synovial fluid (subacromial-subdeltoid bursa, subscapular bursa) or tenosynovial fluid (biceps long head) samples were collected from 9 patients with active PMR. The following T cell subsets were identified by flow cytometry: T naive (CD45RO-CCR7+), central memory (CD45RO+CCR7+), effector memory (CD45RO+CCR7-), effector memory re-expressing CD45RA (CD45RO-CCR7-) cells and CD28null senescent cells. Expression of intracellular cytokines (IL-17A, IFN-γ, IL-4) was determined at 4 hours after stimulation with PMA/calcium ionophore.

Results: The frequencies of all major T cell subsets were similar in the blood of patients with PMR and healthy controls. Synovial fluid of patients with PMR was enriched with effector memory CD4+ and CD8+ T cells, whereas the percentage of CD28null senescent CD8+ T cells was lower in the synovial fluid than in blood. Synovial fluid T cells demonstrated a capacity to produce IFN-γ rather than IL-17 or IL-4.

Conclusion: Synovial fluid T cells in PMR show a non-senescent effector memory phenotype with the capacity to produce IFN-γ, a Th1/Tc1 type cytokine. Our study provides first insights into T cell populations at the site of inflammation in patients with PMR.


Disclosures: R. Reitsema, None; L. Wekema, None; W. Abdulahad, None; P. Heeringa, None; M. Huitema, None; M. Sandovici, None; A. Boots, None; E. Brouwer, Roche, 2, 6; K. van der Geest, Roche, 6.

To cite this abstract in AMA style:

Reitsema R, Wekema L, Abdulahad W, Heeringa P, Huitema M, Sandovici M, Boots A, Brouwer E, van der Geest K. Characterization of Synovial Fluid T Cells in Polymyalgia Rheumatica: Implication of Th1 and Tc1 Effector Memory Profiles [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/characterization-of-synovial-fluid-t-cells-in-polymyalgia-rheumatica-implication-of-th1-and-tc1-effector-memory-profiles/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterization-of-synovial-fluid-t-cells-in-polymyalgia-rheumatica-implication-of-th1-and-tc1-effector-memory-profiles/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology